Tolvaptan for the Treatment of Enlarged Polycystic Liver Disease

A 44-year-old Japanese woman with autosomal dominant polycystic kidney disease was admitted to our hospital for evaluation of abdominal distension. Her eGFR was 53.7 mL/min/1.73 m(2). Total kidney volume was 2,614 mL. Tolvaptan (60 mg/day) was started to treat renal involvement. The patient's a...

Descripción completa

Detalles Bibliográficos
Autores principales: Mizuno, Hiroki, Hoshino, Junichi, Suwabe, Tatsuya, Sumida, Keiichi, Sekine, Akinari, Oshima, Yoichi, Oguro, Masahiko, Kunizawa, Kyohei, Kawada, Masahiro, Hiramatsu, Rikako, Hayami, Noriko, Hasegawa, Eiko, Yamanouchi, Masayuki, Sawa, Naoki, Takaichi, Kenmei, Ubara, Yoshifumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5624279/
https://www.ncbi.nlm.nih.gov/pubmed/29034246
http://dx.doi.org/10.1159/000477664

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5624279/
https://www.ncbi.nlm.nih.gov/pubmed/29034246
http://dx.doi.org/10.1159/000477664

Ejemplares similares